يعرض 1 - 20 نتائج من 176 نتيجة بحث عن '"Buitrago Medina, Daniel Alejandro"', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
  4. 4

    المساهمون: Rodríguez Sánchez, Geovanny, Buitrago-Medina, Daniel-Alejandro

    المصدر: Carsetti, Andrea; Sorbello, Massimiliano; Adrario, Erica; Donati, Abele; Falcetta, Stefano (2022) Airway Ultrasound as Predictor of Difficult Direct Laryngoscopy: A Systematic Review and Meta-analysis. En:Anesthesia & Analgesia; Vol. 134; No. 4; pp. 740-750; 0000000000; Disponible en: 10.1213/ane.0000000000005839.
    Apfelbaum, Jeffrey L.; Hagberg, Carin A.; Connis, Richard T.; Abdelmalak, Basem B.; Agarkar, Madhulika; Dutton, Richard P.; Fiadjoe, John E.; Greif, Robert; Klock, P. Allan; Mercier, David; Myatra, Sheila N.; O’Sullivan, Ellen P.; Rosenblatt, William H.; Sorbello, Massimiliano; Tung, Avery (2021) 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. En:Anesthesiology; Vol. 136; No. 1; pp. 31-81; Disponible en: 10.1097/ALN.0000000000004002.
    Adhikari, Srikar; Zeger, Wes; Schmier, Charles; Crum, Todd; Craven, Andy; Frrokaj, Ilir; Pang, Huiling; Shostrom, Valerie (2011) Pilot study to determine the utility of point-of-care ultrasound in the assessment of difficult laryngoscopy. En:Academic Emergency Medicine; Vol. 18; No. 7; pp. 754-758; Disponible en: 10.1111/j.1553-2712.2011.01099.x.
    R., Backx (2012) NAP4. Major complications of airway management in the United Kingdom. En:Critical Care and Shock; Vol. 15; No. 3; pp. 50-50; 1410-7767; Disponible en: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=71527450.
    Metzner, Julia; Posner, Karen L.; Lam, Michelle S.; Domino, Karen B. (2011) Closed claims' analysis. En:Best Practice and Research: Clinical Anaesthesiology; Vol. 25; No. 2; pp. 263-276; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/j.bpa.2011.02.007. Disponible en: 10.1016/j.bpa.2011.02.007.
    Kristensen, Michael S.; Teoh, Wendy H. (2020) Ultrasonography in Airway Management. En:Benumof and Hagberg’s airway management, third edition; pp. 76-91; Elsevier Inc.; Disponible en: https://doi.org/10.1016/B978-0-323-42881-1.00003-1. Disponible en: 10.1016/B978-0-323-42881-1.00003-1.
    Falcetta, S.; Cavallo, S.; Pelaia, P.; Sorbello, M. (2017) Ultrasound measurements as predictors of difficult direct laryngoscopy. En:Trends in Anaesthesia and Critical Care; Vol. 12; No. 2017; pp. 13-16; Elsevier; Disponible en: http://dx.doi.org/10.1016/j.tacc.2017.01.008. Disponible en: 10.1016/j.tacc.2017.01.008.
    Kraft, Marcel; Mende, Susanne; Arnoux, André; Arens, Christoph (2009) Anatomical Landmarks for Endosonography of the Larynx. En:Head and Neck; Vol. 32; pp. 326-332; Disponible en: 10.1002/HED.
    Gómez-López, L.; Torres, B.; Bergé, R.; Aguirre, O.; Luis, M.; Sala-Blanch, X. (2018) Ultrasound measurement of anatomical parameters of the upper airway in adults. En:Revista Espanola de Anestesiologia y Reanimacion; Vol. 65; No. 9; pp. 495-503; Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor; Disponible en: https://doi.org/10.1016/j.redar.2018.05.007. Disponible en: 10.1016/j.redar.2018.05.007.
    Kristensen, Michael S.; Teoh, Wendy H.; Graumann, Ole; Laursen, Christian B. (2014) Ultrasonography for clinical decision-making and intervention in airway management: From the mouth to the lungs and pleurae. En:Insights into Imaging; Vol. 5; No. 2; pp. 253-279; Disponible en: 10.1007/s13244-014-0309-5.
    Kristensen, M. S. (2011) Ultrasonography in the management of the airway. En:Acta Anaesthesiologica Scandinavica; Vol. 55; No. 10; pp. 1155-1173; Disponible en: 10.1111/j.1399-6576.2011.02518.x.
    Singh, Mandeep; Chin, Ki Jinn; Chan, Vincent W. S.; Wong, David T.; Prasad, Govindarajulu A.; Yu, Eugene (2010) Use of Sonography for Airway Assessment. En:Journal of Ultrasound in Medicine; Vol. 29; No. 1; pp. 79-85; Disponible en: 10.7863/jum.2010.29.1.79.
    Parmar, Siddharthkumar Bhikhabhai; Mehta, Harshil Kirankumar; Shah, Nilima Kanaiyalal; Parikh, Samira Nayan; Solanki, Kunal Govindbhai (2014) Ultrasound: A novel tool for airway imaging. En:Journal of Emergencies, Trauma and Shock; Vol. 7; No. 3; pp. 155-159; Disponible en: 10.4103/0974-2700.136849.
    Koundal, Vishal; Rana, Shelly; Thakur, Ravinder; Chauhan, Vrinda; Ekke, Sony; Kumar, Manuj (2019) The usefulness of point of care ultrasound (POCUS) in preanaesthetic airway assessment. En:Indian Journal of Anaesthesia; Vol. 63; No. 12; pp. 1022-1028; Wolters Kluwer Medknow Publications; Disponible en: 10.4103/ija.IJA_492_19.
    Wu, Jinhong; Dong, Jing; Ding, Yingchun; Zheng, Jijian (2014) Role of anterior neck soft tissue quantifcations by ultrasound in predicting difficult laryngoscopy. En:Medical Science Monitor; Vol. 20; pp. 2343-2350; International Scientific Literature Inc.; Disponible en: 10.12659/MSM.891037.
    Falcetta, Stefano; Cavallo, Simona; Gabbanelli, Vincenzo; Pelaia, Paolo; Sorbello, Massimiliano; Zdravkovic, Ivana; Donati, Abele (2018) Evaluation of two neck ultrasound measurements as predictors of difficult direct laryngoscopy. En:European Journal of Anaesthesiology; Vol. 35; No. 8; pp. 605-612; Lippincott Williams and Wilkins; Disponible en: 10.1097/EJA.0000000000000832.
    Frerk, C.; Mitchell, V. S.; McNarry, A. F.; Mendonca, C.; Bhagrath, R.; Patel, A.; O'Sullivan, E. P.; Woodall, N. M.; Ahmad, I. (2015) Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. En:British Journal of Anaesthesia; Vol. 115; No. 6; pp. 827-848; Elsevier Ltd; Disponible en: 10.1093/bja/aev371.
    ASA (2013) Practice Guidelines for Management of the Difficult Airway. En:Anesthesiology; Vol. 118; pp. 251-70
    Artime, Carlos A; Hagberg, Carin A (2020) Airway Management in the Adult. En:Miller's Anesthesia, Ninth Edition; pp. Chapter 44-Chapter 44; Disponible en: 10.1016/B978-0-323-59604-6.00044-4.
    Alessandri, Francesco; Antenucci, Giuseppe; Piervincenzi, Edoardo; Buonopane, Costantino; Bellucci, Riccardo; Andreoli, Chiara; Alunni Fegatelli, Danilo; Ranieri, Marco V; Bilotta, Federico (2019) Ultrasound as a new tool in the assessment of airway difficulties. En:European journal of anaesthesiology; Disponible en: 10.1097/EJA.0000000000000989.
    Berkow, Lauren C.; Ariyo, Promise (2015) Preoperative assessment of the airway. En:Trends in Anaesthesia and Critical Care; Vol. 5; No. 1; pp. 28-35; Churchill Livingstone; Disponible en: 10.1016/j.tacc.2014.11.003.
    Soni, Nilam J.; Arntfield, Robert; Kory, Pierre; Point-of-care ultrasound. 9781455775699
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: 45 pp; application/pdf; application/octet-stream

  5. 5

    المساهمون: Buitrago-Medina, Daniel-Alejandro, Varona-Uribe, Marcela

    المصدر: Kim JJ, Kim YS, Kumar V. Heavy metal toxicity: An update of chelating therapeutic strategies. J Trace Elem Med Biol. 2019 Jul; 54:226-231. doi: 10.1016/j.jtemb.2019.05.003. Epub 2019 May 10. PMID: 31109617
    Gómez-Arroyo, S., Martínez-valenzuela, C., Carbajal-lópez, y, Martínez-Arroyo, A., Calderón-Segura, M. E., Villalobos-Pietrini, R., & Waliszewski, S. M. Riesgo genotóxico por la exposición ocupacional a plaguicidas en América Latina. Revista internacional de contaminación ambiental, 2013; 29, 159-180.
    Mesic A, Nefic H. Assessment of the genotoxicity and cytotoxicity in environmentally exposed human populations to heavy metals using the cytokinesis-block micronucleus cytome assay. Environmental toxicology. 2015 Nov;30(11):1331-42.
    Bolognesi C. Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat Res. 2003 Jun;543(3):251-72. doi: 10.1016/s1383-5742(03)00015-2. PMID: 12787816.
    Martínez-Valenzuela, C., & Gómez-Arroyo, S. Riesgo genotóxico por exposición a plaguicidas en trabajadores agrícolas. Revista internacional de contaminación ambiental, (2007). 23(4), 185-200.
    Palus J, Rydzynski K, Dziubaltowska E, Wyszynska K, Natarajan AT, Nilsson R. Genotoxic effects of occupational exposure to lead and cadmium. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2003 Sep 9;540(1):19-28.
    Sarto F, Stella M, Acqua A. Cyto-genetic studies in 20 workers occupationally exposed to lead. Medicina del Lavoro. 1978;69(2):172-80.
    Nordenson I, Beckman G, Beckman L, Nordström S. Occupational and environmental risks in and around a smelter in northern Sweden IV. Chromosomal aberrations in workers exposed to lead. Hereditas. 1978 Jul;88(2):263-7
    Rosales-Rimache JA, Malca E, Alarcón JJ, Chávez M, Gonzáles MA. Genotoxic damage among artisanal and small-scale mining workers exposed to mercury. Revista peruana de medicina experimental y salud pública. 2013 Oct 1;30(4):595-600.
    Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Molecular, clinical and environmental toxicology. 2012:133-64.
    Stannard L, Doak SH, Doherty A, Jenkins GJ. Is nickel chloride really a non-genotoxic carcinogen?. Basic & clinical pharmacology & toxicology. 2017 Sep; 121:10-5.
    Benedetti D, Lopes Alderete B, de Souza CT, Ferraz Dias J, Niekraszewicz L, Cappetta M, Martínez-López W, Da Silva J. DNA damage and epigenetic alteration in soybean farmers exposed to complex mixture of pesticides. Mutagenesis. 2018 Jan;33(1):87-95.
    Uwizeyimana H, Wang M, Chen W, Khan K. The eco-toxic effects of pesticide and heavy metal mixtures towards earthworms in soil. Environmental toxicology and pharmacology. 2017 Oct 1;55:20-9
    Varona M, Cárdenas O, Crane C, Rocha S, Cuervo G, Vargas J. Cytogenetic alterations in field workers routinely exposed to pesticides in Bogota flowers farms. Biomedica. 2003 Jun 1;23(2):141-52.
    Calao CR, Marrugo JL. Genotoxic effects in a human population exposed to heavy metals in the region of La Mojana, Colombia, 2013. Biomédica. 2015 Aug;35(SPE):139-51.
    Madrid G, Gracia L, Marrugo JL, Urango I. Genotoxicity studies of heavy metals: Hg, Zn, Cu, Pb y Cd related to mining operations on residents of San Jorge basin, Department of Cordoba, Colombia. Rev Asoc Col Cienc (Col). 2011;23:103-11
    Gajski G, Gerić M, Oreščanin V, Garaj-Vrhovac V. Cytokinesis-block micronucleus cytome assay parameters in peripheral blood lymphocytes of the general population: contribution of age, sex, seasonal variations and lifestyle factors. Ecotoxicology and environmental safety. 2018 Feb 1;148:561-70.
    León-Mejía G, Quintana M, Debastiani R, Dias J, Espitia-Pérez L, Hartmann A, Henriques JA, Da Silva J. Genetic damage in coal miners evaluated by buccal micronucleus cytome assay. Ecotoxicology and Environmental Safety. 2014 Sep 1;107:133-9.
    Bolognesi C, Creus A, Ostrosky-Wegman P, Marcos R. Micronuclei and pesticide exposure. Mutagenesis. 2011 Jan;26(1):19-26
    Gracia L, Chams L, Hoyos W, Marrugo J. Relación de consumo de pescado y niveles de mercurio en pobladores aledaños al río San Jorge, Colombia (2016).
    Benassi-Evans B, Fenech M. Chronic alcohol exposure induces genome damage measured using the cytokinesis-block micronucleus cytome assay and aneuploidy in human B lymphoblastoid cell lines. Mutagenesis. 2011 Jan 27;26(3):421-9.
    Donmez-Altuntas H, Bitgen N. Evaluation of the genotoxicity and cytotoxicity in the general population in Turkey by use of the cytokinesis-block micronucleus cytome assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2012 Oct 9;748(1-2):1-7
    Martínez-Valenzuela C, Gómez-Arroyo S. Riesgo genotóxico por exposición a plaguicidas en trabajadores agrícolas. Revista internacional de contaminación ambiental. 2007 Dec;23(4):185-200
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: 24 pp; application/pdf

  6. 6
    Academic Journal
  7. 7
  8. 8
  9. 9
    Academic Journal

    Relation: http://dx.doi.org/10.18270/rce.v14i.2026; https://hdl.handle.net/20.500.12494/4793; Jaramillo, G. I., Vásquez, D. C., & Buitrago, D. A. (2017). Preeclampsia leve y severa: estudio de casos y controles en el Hospital de Chiquinquirá 2012-2014. Revista Colombiana de Enfermería, 14(12), 33-43. http://dx.doi.org/10.18270/rce.v14i.2026

  10. 10

    المساهمون: Figueroa, Jair, Huerfano, Manuel, Buitrago-Medina, Daniel-Alejandro

    المصدر: Chang C, Chien W, Chung C, Lee J, Hsu S, Chen J. Impact of hemodialysis on the prognosis of multiple myeloma: A nationwide population-based study and single-institute analysis. Oncology Letters. 2018
    Berni Wennekers A, Martín Azara M, Dourdil Sahun V, Bergasa Liberal B, Ruiz Laiglesia J, Vernet Perna P et al. Trece tratamientos de la insuficiencia renal aguda secundaria a mieloma múltiple con filtros de high cut off. Nefrología. 2016.
    Wirk B. Renal failure in multiple myeloma: a medical emergency. Bone Marrow Transplantation. 2011
    Yadav P, Hutchison C, Basnayake K, Stringer S, Jesky M, Fifer L et al. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysisdependent acute kidney injury. European Journal of Haematology. 2015.
    Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrology Dialysis Transplantation. 1 de abril de 2010
    Hutchison C, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nature Reviews Nephrology. 2011.
    Favà A, Fulladosa X, Montero N, Draibe J, Torras J, Gomà M, et al. Treatment of multiple myeloma with renal involvement: the nephrologist’s view. Clinical Kidney Journal. 1 de diciembre de 2018
    Leung N, Behrens J. Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients. Advances in Chronic Kidney Disease. septiembre de 2012
    Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrology Dialysis Transplantation. 1 de febrero de 2010
    Decourt A, Gondouin B, Delaroziere J, Brunet P, Sallée M, Burtey S et al. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Clinical Journal of the American Society of Nephrology. 2016
    Korbet S. Multiple Myeloma. Journal of the American Society of Nephrology. 2006
    Tapson JS, Mansy H, Wilkinson R. End-stage renal failure due to multiple myelomapoor survival on peritoneal dialysis. Int J Artif . Organs 1988; 11: 39–42
    Pozzi C, D'Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003
    Goldschmidt H, Lannert H, Bommer J et al. Multiple myeloma and renal failure. Nephrol Dial Transplant 2000
    Batuman V, et al. Myeloma light chains are ligands for cubilin (gp280). Am. J. Physiol. 1998
    Klassen RB, Allen PL, Batuman V, Crenshaw K, Hammond TG. Light chains are a ligand for megalin. J. Appl. Physiol. 2005.
    Li M, Hering-Smith KS, Simon EE, Batuman V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant. 2008
    Pote A, Zwizinski C, Simon EE, Meleg-Smith S, Batuman V. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am. J. Kidney Dis. 2000
    Sengul S, Zwizinski C, Batuman V. Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells. Am. J. Physiol. Renal Physiol. 2003
    Sengul S, et al. Endocytosis of light chains induces cytokines through activation of NF-κB in human proximal tubule cells. Kidney Int. 2002
    Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab. Invest. 1991
    Drayson M, et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventionaldose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood. 2006
    Terpos E, Roodman E, Dimopoulus M. Optimal use of bisphosphonates in patients with multiple myeloma. BLOOD, 25. April 2013
    Copyright and License Information. Section 5: dialysis interventions for treatment of AKI. Kidney Int Suppl (2011). Nature, 2012
    Ahmad M. Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma. International Urology and Nephrology. 2007
    Cook M, Hutchison C, Fifer L, Gillmore J, Heyne N, Weisel K et al. High cut-off haemodialysis (HCO-HD) does not improve outcomes in myeloma cast nephropathy: results of European trial of Free Light Chain removal extended haemodialysis in cast nephropathy (EULITE). EHA Learning Center. Cook M. Jun. 2016
    Dimopoulos MA, Roussou M, Gavriatopoulou M, et al. Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. Blood Cancer J. 2017
    Sakhuja V, Jha V, Varma S, Joshi K, Gupta K, Sud K et al. Renal involvement in multiple myeloma: a 10-year study. Renal Failure. 2000.
    Blade L, Fernández-Llama R, Bosch E, Montoliu J, Lens W, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E: Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998
    Reyes M, Valera A, Frutos A, Ramos B, Ordoñez V, Lopez De Novales E. Supervivencia de pacientes con mieloma tratados con diálisis. Nefrología. 2003
    Hsu C, Ordoñez J, Chertow G, Fan D, McCulloch C, Go A. The risk of acute renal failure in patients with chronic kidney disease. Kidney International. 2008
    Hutchison C, Bradwell A, Cook M, Basnayake K, Basu S, Harding S et al. Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis. Clinical Journal of the American Society of Nephrology. 2009
    Bridoux F, Carron P, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A et al. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy. JAMA. 2017
    Antlanger M, Dust T, Reiter T, Böhm A, Lamm W, Gornicec M et al. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer. 2018
    Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: 32 pp.; application/pdf

  11. 11

    المساهمون: Rivera-Nieto, Carolina, Buitrago-Medina, Daniel-Alejandro

    المصدر: Intong LRA, Murrell DF. Inherited epidermolysis bullosa: New diagnostic criteria and classification. Clin Dermatol [Internet]. 2012;30(1):70–7. Available from: http://dx.doi.org/10.1016/j.clindermatol.2011.03.012
    Fine J. Inherited epidermolysis bullosa. 2010;1–17.
    Qué es EB – Debra Colombia [Internet]. [cited 2021 Mar 16]. Available from: https://debracolombia.org/que-es-eb/
    Torres-Iberico R, Palomo-Luck P, Torres-Ramos G, Lipa-Chancolla R. Epidermolysis bullosa in Peru: Clinical and epidemiological study of patients treated in a national reference pediatric hospital, 1993-2015. Rev Peru Med Exp Salud Publica. 2017;34(2):201–8.
    Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis Bullosa registry. JAMA Dermatology. 2016;152(11):1231–8.
    Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa : best clinical practice guidelines. 2015;1–12.
    Pareja Arcila ML. Situación actual de las enfermedades huérfanas en Colombia 2017. CES Derecho. 2017;8(2):231–41.
    Pages-Catálogo de información [Internet]. [cited 2021 Mar 16]. Available from: https://www.sispro.gov.co/catalogos/Pages/catalogo-de-informacion.aspx
    Zillmann G, Ga P, Kra SM, Carrasco-labra A, Oliva P, Araya I. Oral Health Care for Patients with Epidermolysis Bullosa-Best Clinical Practice Guidelines. 2012;1–35.
    Goldschneider KR, Good J, Harrop E, Liossi C, Lynch-jordan A, Martinez AE, et al. Pain care for patients with epidermolysis bullosa : best care practice guidelines. 2014;1–23
    Fine JD, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58(6):931–50.
    Uitto J, Bruckner-Tuderman L, Christiano A, McGrath JA, Has C, South A, et al. Progress Towards Treatment and cure of Epidermolysis Bullosa: Summary of theDEBRA International Research Symposium EB2015. J Invest Dermatology. 2016;136(1):352–8.
    Sawamura D, Nakano H, Matsuzaki Y. Overview of epidermolysis bullosa. J Dermatol. 2010;37(3):214–9.
    Vergara P, Vergara Amador E, Solaque H. De Casos Presentación. 14:274–80. Available from: http://www.scielo.org.co/pdf/rfmun/v57n3/v57n3a08.pdf
    Barbosa NM, Visioli F, Martins MD, Martins MAT, Munerato MC. Oral manifestations in Kindler syndrome: case report and discussion of literature findings. Spec Care Dent. 2016;36(4):223–30
    Yenamandra VK, Moss C, Sreenivas V, Khan M, Sivasubbu S, Sharma VK, et al. Development of a clinical diagnostic matrix for characterizing inherited epidermolysis bullosa *. 2017;1624–32
    V AD, Has C, Küsel J, Reimer A, Hoffmann J, Schauer F, et al. The Position of Targeted Next-generation Sequencing in Epidermo ­ lysis Bullosa Diagnosis. 2018;437–40.
    Cohn HI, Teng JMC. Advancement in management of epidermolysis bullosa. Curr Opin Pediatr. 2016;28(4):507–16
    Epidermolysis bullosa-Treatment-NHS [Internet]. [cited 2021 Mar 16]. Available from: https://www.nhs.uk/conditions/epidermolysis-bullosa/treatment/
    Lloyd C, Yu QC, Cheng J, Turksen K, Degenstein L, Hutton E, et al. The basal keratin network of stratified squamous epithelia: Defining K15 function in the absence of K14. J Cell Biol. 1995;129(5):1329–44
    Pathogenesis BL, Bruckner-tuderman L. Pathogenesis of mechanobuUous disorders. 1992;115–20.
    Nacional SP. Informe Rápido de Contexto ( IRC ) Características y Prevalencia de la Epidermolisis Bullosa o Ampollar. 2011;1–5.
    Vázquez Estévez JJ. Eficacia del tratamiento con piel quimérica cultivada de las lesiones cutáneas en pacientes con epidermolisis bullosa distrófica recesiva . 2012;1–233
    Alvarez O, Ortiz Robayo D. Caracteristicas demograficas, clinicas y farmacologicas de pacientes con epidermolisis Bullosa: Estudio de corte transversal. 2016
    Sierra M. Tema : “ Evolución Clínica De La Epidermiolisis Bullosa Neonatal En El Servicio De Neonatología Hospital Para El Niño Imiem .” 2014
    Revuelta LA, Ruíz DR, Guerra D, Bravo E. Epidermólisis bullosa. Presentación de un caso. Epydermolisis Bullosa. Case presentation. 2016;22–34. Available from: http://scielo.sld.cu/pdf/ms/v14n6/ms17614.pdf
    D’Amato-Gutierrez M, García M, Giraldo G, Bayona CT, Garrido A, Orozco JC, et al. Reporte de Caso. Epidermolisis Bullosa distrófica hereditaria en gemelas. Medellín, Colombia. Rev argentina dermatología. 2019;100(2):51–60
    García-Romero MT, Becerril-Rico J, Dabdoub-Hernández AA. Epidermolysis bullosas: An analysis of the cost of medical care in Mexico. Med Interna Mex. 2019;35(1):30–8
    García Cruz EX, de la Teja Ángeles E, Durán Gutiérrez LA. Rehabilitación bucal bajo anestesia general en un paciente pediátrico con diagnóstico de epidermólisis bullosa. Reporte de un caso. Rev Odontológica Mex [Internet]. 2013;17(2):111–6. Available from: http://dx.doi.org/10.1016/S1870-199X(13)72025-1
    Vidal G, Carrau F, Lizarraga M, Álvarez M. Epidermólisis ampollar: a propósito de un caso clínico Epydermolisis bullosa, one clinical case Epidermólise bolhosa, um caso clínico. 2018;89(6):382–8
    Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006. J Am Acad Dermatol [Internet]. 2009;60(2):203–11. Available from: http://dx.doi.org/10.1016/j.jaad.2008.09.035
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: 41 pp.; application/pdf

  12. 12
  13. 13

    المساهمون: Varona-Uribe, Marcela, Buitrago-Medina, Daniel-Alejandro, Polo Alvarado, Bertha Eugenia

    المصدر: Decreto 1278. Por el cual se expide el Estatuto de Profesionalización Docente. Bogotá:; 2002 Junio 19.
    Arango D, Arrieta E, Sepúlveda C, Vélez M. Informe de seguimiento sobre salud y estabilidad en el empleo. Medellín: Centro de Estudios Sociales y Laborales; 2018.
    Comité Mixto OIT-OMS. 9na Reunión. ; 1984.
    Martínez E, Saldarriaga J. Factores asociados al ausentismo laboral por causa médica en una institución de educación superior. Revista Facultad Nacional de Salud Pública. 2007; 25(1): p. 9-32.
    Lozada M. La docencia: ¿un riesgo para la salud?. Avances en Enfermería. 2005; 23(1): p. 18-30.
    Guan Y, Ling K, Ying P. Systematic review on the prevalence of illness and stress and their associated risk factors among educators in Malaysia. Journal Plos. 2019 Mayo 28.
    Goulart E, Novaes M. Estrés entre los profesores de la enseñanza fundamental de las escuelas públicas estaduales. Psicologia em Estudo. 2008; 13(4): p. 847-857.
    Gómez G, González V, Londoño S. Percepción de los docentes frente a la carga laboral de un grupo de instituciones educativas colombianas del sector público. Revista Espacios. 2019; 4(2): p. 26.
    Macías Y. Ausentismo laboral por origen médico durante el período julio 2017 a junio 2018 de los docentes de una corporación educativa. Universidad de Antioquia; 2018.
    Castro C, Sánchez A.. Salud y trabajo de docentes de instituciones educativas distritales de la localidad uno de Bogotá. Avances en enfermería. 2013 Julio 1; 31(2): p. 30-42.
    Medeiros A, Vieira M. Work absenteeism due to voice disorders in Brazilian schoolteachers. 2019;35. Cadernos de Saúde Pública. 2019; 35(1).
    Fasecolda. Se reducen las enfermedades laborales, pero aumentan las incapacidades en Colombia. [Online].; 2019. Available from: https://fasecolda.com/sala-de-prensa/fasecolda-en-linea/noticias/noticias-2019/noviembre/se-reducen-las-enfermedades-laborales-pero-aumentan-las-incapacidades-en-colombia.
    Pino S, Ponce G. Comportamiento de la enfermedad laboral en Colombia 2015-2017. Revista Fasecolda. 2019;(175): p. 48-55.
    Pinilla B, Hernádez B, Polo B, Gómez C, Rodríguez C, Mejía D, et al. Ausentismo laboral, reintegro y rehabilitación. Primera ed. Bogotá: Sociedad Colombiana de Medicina del Trabajo; 2020.
    Organización Mundial de la Salud. El número de accidentes y enfermedades relacionados con el trabajo sigue aumentando. [Online].; 2005 [cited 2020 Noviembre 9. Available from: https://www.who.int/mediacentre/news/releases/2005/pr18/es/#:~:text=Las%20enfermedades%20profesionales%20m%C3%A1s%20comunes,por%20exposici%C3%B3n%20a%20agentes%20pat%C3%B3genos.
    Arrieta E, Fernández C, Sepúlveda C, Vieco J. Tercer informe de seguimiento sobre ausentismo laboral e incapacidades médicas. Medellín: ANDI; 2019.
    Körner A, Robalino M. Estudios de casos en Argentina, Chile, Ecuador, México, Perú y Uruguay. Santiago de Chile: UNESCO; 2005.
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  14. 14

    المساهمون: Buitrago-Medina, Daniel-Alejandro, Motta Velasco, Angela María

    المصدر: 1. Crerand CE, Menard W, Phillips KA. Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder. Ann Plast Surg. julio de 2010;65(1):11-6.
    Rayess HM, Svider PF, Hanba C, Patel VS, DeJoseph LM, Carron M, et al. A Cross-sectional Analysis of Adverse Events and Litigation for Injectable Fillers. JAMA Facial Plast Surg. 21 de diciembre de 2017.
    3. plastic-surgery-statistics-report-2018.pdf [Internet]. Disponible en: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf
    4. Emer J, Waldorf H. Injectable neurotoxins and fillers: there is no free lunch. Clin Dermatol. diciembre de 2011;29(6):678-90.
    5. Townshend A. Blindness After Facial Injection. J Clin Aesthetic Dermatol. diciembre de 2016;9(12):E5-7.
    6. Lee JI, Kang SJ, Sun H. Skin Necrosis with Oculomotor Nerve Palsy Due to a Hyaluronic Acid Filler Injection. Arch Plast Surg. julio de 2017;44(4):340-3.
    7. Prado G, Rodríguez-Feliz J. Ocular Pain and Impending Blindness During Facial Cosmetic Injections: Is Your Office Prepared? Aesthetic Plast Surg. febrero de 2017;41(1):199-203.
    8. Wang Q, Zhao Y, Li H, Li P, Wang J. Vascular Complications After Chin Augmentation Using Hyaluronic Acid. Aesthetic Plast Surg. 19 de diciembre de 2017.
    9. Schelke LW, Fick M, van Rijn LJ, Decates T, Velthuis PJ, Niessen F. [Unilateral blindness following a non-surgical rhinoplasty with filler]. Ned Tijdschr Geneeskd. 2017;161(0):D1246.
    11. Safety Alerts for Human Medical Products > Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication-Risk of Serious Patient Injury [Internet]. [cited 2018 Apr 28]. Available from: https://wayback.archive-it.org/7993/20170406123714/https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm448439.htm
    12. alertaHialuronicorevisadaiii.pdf [Internet]. [cited 2018 Apr 28]. Available from: https://www.invima.gov.co/images/pdf/tecnovigilancia/informes_seguridad/Alertas_internacionales_2015/alertaHialuronicorevisadaiii.pdf
    13. Goodman GJ, Roberts S, Callan P. Experience and Management of Intravascular Injection with Facial Fillers: Results of a Multinational Survey of Experienced Injectors. Aesthetic Plast Surg. agosto de 2016;40(4):549-55.
    14. Urdiales-Gerts S, Callan P. Experience and Management of Intravascular Injection withTreatment of Soft Tissue Filler Complications: Expert Consensus Recommendations. Aesthetic Plast Surg. 2018 Apr;42(2):498–510.
    15. Fitzgerald R, Bertucci V, Sykes JM, Duplechain JK. Adverse Reactions to Injectable Fillers. Facial Plast Surg FPS. octubre de 2016;32(5):532-55.
    16. Urdiales-Gt Surg FPS. octubre de 2016;32(5):532-55. aza JV, Mira M, Moreno A, et al. Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations. Aesthetic Plast Surg. 2018 Apr;42(2):498–510.a
    17. Poljšak B., Dahmane R., Godic A. Intrinsic skin aging: The role of oxidative stress. Acta Dermatovenerol APA | 2012;21:1-4
    18. Amano S. Characterization and mechanisms of photoageing-related changes in skin. Damages of basement membrane and dermal structures. Experimental Dermatology. 2016;25:14-19
    19. Gilchrest B. Photoaging. J Invest Dermatol. 2013;1;133(E1):E2-6
    El-Domyati M, Attia S, Saleh F, Brown D, Birk D, Gasparro F et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Experimental Dermatology. 2002;11(5):398-405.
    21. McDaniel D, Farris P, Valacchi G. Atmospheric skin aging-Contributors and inhibitors. Journal of Cosmetic Dermatology. 2018;17(2):124-137.
    22. Weissler J, Carney M, Carreras Tartak J, Bensimon R, Percec I. The Evolution of Chemical Peeling and Modern-Day Applications. Plastic and Reconstructive Surgery. 2017;140(5):920-929.
    Wulc AE, Sharma P, Czyz CN. The anatomic basis of midfacial aging. En: Harstein ME, Wulc AE, Holch DE (eds) Midfacial rejuvenation. Springer, Heidelberg; 2012: 15–28
    24. Mammucari M, Gatti A, Maggiori S, Bartoletti CA, Sabato AF. Mesotherapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy. Eur Rev Med Pharmacol Sci. junio de 2011;15(6):682-94.
    25. Lee JC, Daniels MA, Roth MZ. Mesotherapy, Microneedling, and Chemical Peels. Clin Plast Surg. julio de 2016;43(3):583-95.
    26. Afrooz PN, Pozner JN, DiBernardo BE. Noninvasive and minimally invasive techniques in body contouring. Clin Plast Surg. octubre de 2014;41(4):789-804.
    27. Duncan D, Rotunda AM. Injectable therapies for localized fat loss: state of the art. Clin Plast Surg. julio de 2011;38(3):489-501, vii.
    28. Jayasinghe S, Guillot T, Bissoon L, Greenway F. Mesotherapy for local fat reduction. Obes Rev Off J Int Assoc Study Obes. octubre de 2013;14(10):780-91.
    29. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. abril de 2006;32(4):465-80.
    30. Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A. Botulinum Toxin Off-Label Use in Dermatology: A Review. Skin Appendage Disord. marzo de 2017;3(1):39-56
    31. de Maio M, DeBoulle K, Braz A, Rohrich RJ, Alliance for the Future of Aesthetics Consensus Committee. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Midface. Plast Reconstr Surg. octubre de 2017;140(4):540e-550e.
    32. Giordano CN, Matarasso SL, Ozog DM. Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies. J Am Acad Dermatol. junio de 2017;76(6):1027-42.
    33. França K, Kumar A, Fioranelli M, Lotti T, Tirant M, Roccia M. The history of Botulinum toxin: from poison to beauty. Wiener Medizinische Wochenschrift. 2017;167(S1):46-48.
    34. Ozturk C, Li Y, Tung R, Parker L, Piliang M, Zins J. Complications Following Injection of Soft-Tissue Fillers. Aesthetic Surgery Journal. 2013;33(6):862-877.
    35. Cox S, Adigun C. Complications of injectable fillers and neurotoxins. Dermatologic Therapy. 2011;24(6):524-536.
    36. Walker K, Pellegrini MV. Hyaluronic Acid. [Updated 2018 Jan 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan.
    GreeneJ et Al. The Hyaluronic Acid Fillers. Current Understanding of the Tissue Device Interface. Facial Plast Surg Clin N Am. 2015; 23: 423–432
    38. Hersant, J.P. Meningaud. Hyaluronic acid rheology: Basics and clinical applications in facial rejuvenation. Annales de chirurgie plastique esthétique. 201762, 261—267
    39. Kadouch J. Calcium hydroxylapatite: A review on safety and complications. Journal of Cosmetic Dermatology. 2017;16(2):152-161.
    40. Tracy L, Ridgway J, Nelson J, Lowe N, Wong B. Calcium hydroxylapatite associated soft tissue necrosis: A case report and treatment guideline. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2014;67(4):564-568.
    41. Pavicic T. Calcium hydroxylapatite filler: an overview of safety and tolerability. J Drugs Dermatol. 2013,12(9):996-1002.
    42. Rotunda A, Narins R. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatologic Therapy. 2006;19(3):151-158.
    43. Lee J, Lorenc Z. Synthetic Fillers for Facial Rejuvenation. Clinics in Plastic Surgery. 2016;43(3):497-503
    44. de Melo F, Nicolau P, Piovano L, Lin SL, Baptista-Fernandes T and cols. Recommendations for volumen augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clin Cosmet Investig Dermatol. 2017:10 431–440
    45. Pallua N, Wolter T, Markowicz M. Platelet-rich plasma in burns. Burns. 2010;36(1):4-8.
    46. Elghblawi E. Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering. Journal of Cosmetic Dermatology. 2017: 1-8.
    47. Chiang Y, Pierone G, Al-Niaimi F. Dermal fillers: pathophysiology, prevention and treatment of complications. Journal of the European Academy of Dermatology and Venereology. 2016;31(3):405-413.
    48. Levy LL, Emer JJ. Complications of minimally invasive cosmetic procedures: prevention and management. J Cutan Aesthetic Surg. abril de 2012;5(2):121-32.
    49. DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J. 1 de mayo de 2014;34(4):584-600.
    50. Cohen JL, Biesman BS, Dayan SH, et al. Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations. Aesthet Surg J. 2015;35(7):844-849.
    51. Henderson R, Reilly DA, Cooper JS. Hyperbaric Oxygen for Ischemia due to Injection of Cosmetic Fillers: Case Report and Issues. Plast Reconstr Surg Glob Open. 2018;6(1):e1618.
    52. Van Loghem J, Funt D, Pavicic T, et al. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus [published online ahead of print, 2020 Mar 17]. J Cosmet Dermatol. 2020.
    Kalyam K, Kavoussi S, Ehrlich M, Teng C, Chadha N, Khodadadeh S et al. Irreversible Blindness Following Periocular Autologous Platelet-Rich Plasma Skin Rejuvenation Treatment. Ophthalmic Plastic and Reconstructive Surgery. 2017;33:S12-S16.
    54. Loh KT, Chua JJ, Lee HM, et al. Prevention and management of vision loss relating to facial filler injections. Singapore Med J. 2016;57(8):438-443.
    55. Carruthers J, Fagien S, Dolman P. Retro or PeriBulbar Injection Techniques to Reverse Visual Loss After Filler Injections. Dermatol Surg. 2015;41 Suppl 1:S354-S357.
    56. Jones, Jill K. Bennett, Sharon Erlandsson, et al. Aesthetic Medicine Nurses and Qualified Nonmedical Practitioners: Our Role and Requirements as Aesthetic Medicine Adapts to Worldwide Changes and Needs, Plastic Surgical Nursing: October/December 2018-Volume 38-Issue 4-p 153-157
    57. Helena Collier, Nurses with inadequate skills should not be practising aesthetic medicine. Journal of Aesthetic Nursing 2018 7:6, 322-323
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  15. 15

    المساهمون: Arango Duque, Alvaro Ignacio, Buitrago-Medina, Daniel-Alejandro

    المصدر: Zhong D, Liang SY. Approach to Transplant Infectious Diseases in the Emergency Department. Emerg Med Clin North Am [Internet]. 2018;36(4):811–22. Available from: https://doi.org/10.1016/j.emc.2018.06.010
    Et DG, Martín C. NEWSLETTER TRANSPLANT International figures on donation and transplantation PRODUCED BY THE COUNCIL OF EUROPE EUROPEAN COMMITTEE [Internet]. Vol. 23. 2018. Available from: http://www.transplant-observatory.org/
    National Data-OPTN. U.S. Department of Health & Human Services Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#. Accessed February 5, 2019 [Internet]. Available from: https://optn.transplant.hrsa.gov/data/
    Salud IN de. Informe anual Red de Donación y Trasplantes 2018. 2018.
    Fishman JA, Issa NC. Infection in organ transplantation: risk factors and evolving patterns of infection. Infect Dis Clin North Am [Internet]. 2010;24(2):273–83. Available from: http://dx.doi.org/10.1016/j.idc.2010.01.005
    Fishman JAMD. Infection in Solid-Organ Transplant RecipientsMedical Progress. N Engl J Med [Internet]. 2007;357(25):2601–14. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://search.proquest.com/docview/223931283?accountid=14757%0Ahttp://dd8gh5yx7k.search.serialssolution.com?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&rfr_id=info:sid/ProQ%3Ahealthcompleteshell&rft_val_fmt=
    Fishman JA. Infection in Organ Transplantation. Am J Transplant. 2017;17(4):856–79.
    Lumbreras C, Manuel O, Len O, ten Berge IJM, Sgarabotto D, Hirsch HH. Cytomegalovirus infection in solid organ transplant recipients C. Clin Microbiol Infect. 2014;20(7):19–26.
    Alraies MC, Eckman P. Adult heart transplant: Indications and outcomes. J Thorac Dis. 2014;6(8):1120–8.
    Patiño-López M, Echeverri-Toro L, Bonfante-Olivares L, Atehortúa-Muñoz S, Ospina-Ospina S. Infecciones tempranas en pacientes trasplantados en un hospital de alta complejidad TT-Early infections in transplant patients in a quaternary care hospital. Infectio [Internet]. 2017;21(3):148–53. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922017000300148
    Sanabria P. INCIDENCIA Y FACTORES ASOCIADOS A INFECCION EN EL PRIMER AÑO POSTRAPLANTE CARDIACO. Universidad del Rosario; 2016.
    Daza J. Incidencia Y Factores Asociados a Infecciones Bacterianas En El Primer Mes Postrasplante [Internet]. Universidad del Rosario; 2015. Available from: http://repository.urosario.edu.co/bitstream/handle/10336/11842/80197071.pdf
    Blair BM. Safe Living Following Solid Organ Transplantation. Surg Clin North Am [Internet]. 2019;99(1):153–61. Available from: https://doi.org/10.1016/j.suc.2018.09.011
    Clyde Y, Mariell J. 2013 ACCF / AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol [Internet]. 2013;62(16):e147–239. Available from: http://dx.doi.org/10.1016/j.jacc.2013.05.019
    Vucicevic D, Honoris L, Raia F, Deng M. Current indications for transplantation : stratification of severe heart failure and shared decision-making. 2018;7(1):56–66.
    Crespo-leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(11):1505–35.
    Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. Criterios de inclusión en lista de espera para trasplante cardiaco de la International Society for Heart and Lung Transplantation, 2016: una actualización de 10 años. J Hear Lung Transplant. 2016;35(1).
    Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Hear Lung Transplant. 2015;35:1–23.
    Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, et al. The registry of the international society for heart and lung transplantation: Twenty-eighth adult heart transplant report-2011. J Hear Lung Transplant [Internet]. 2011;30(10):1078–94. Available from: http://dx.doi.org/10.1016/j.healun.2011.08.003
    Villegas A, Fernández D. Consideraciones y experiencia con el trasplante cardíaco. Rev Colomb Cir. Vol. 14(1). 1999. p. 02–10.
    Gomez J, Flórez N, Olaya P, Jaramillo S, Chica J, Ramos M, et al. Mortalidad precoz en trasplante cardíaco. Rev Colomb Cardiol. 2017;24(5):442–7.
    Zalaquett R. 50 AÑOS DE TRASPLANTE DE CORAZÓN La operación que enmudeció al mundo y cambió para siempre el concepto de muerte 50 YEARS AFTER THE FIRST HEART TRANSPLANT The operation that stunned the world and for ever changed the concept of death. Rev Chil Cardiol. 2017;36:275–82.
    Costanzo MR, Force T, Rosa M, Dipchand CA, Starling R, Writers C, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. HEALUN [Internet]. 2010;29(8):914–56. Available from: http://dx.doi.org/10.1016/j.healun.2010.05.034
    Cardíaco T, Bohórquez LF, Briceño JC, Biomédico I, Osorno JB, Sánchez JD, et al. revista colombiana de. 2009
    Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, et al. Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. N Engl J Med. 2018;379(5):440–53.
    Redfield R, Schchat A, Rochards C, Al E. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. Vol. 69, Morbidity and Mortality Weekly Report. 2020.
    Gibril N, Sapna M, Rachel W, Al E. Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. 2018;55(2):244–52.
    Abbo LM, Antonio P, Community ID. Surgical site infections : Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin trasplatation. 2019;00(May):1–19.
    Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Hear Lung Transplant [Internet]. 2010;29(8):914–56. Available from: http://dx.doi.org/10.1016/j.healun.2010.05.034
    Manito N. Treinta años de trasplante cardiaco en España Introducción. Resvista Española Cardiol. 2015;15(B):1–7.
    Söderlund C, Rådegran G. Immunosuppressive therapies after heart transplantation-The balance between under-and over-immunosuppression. Transplant Rev [Internet]. 2015;29(3):181–9. Available from: http://dx.doi.org/10.1016/j.trre.2015.02.005
    Van De Beek D, Kremers WK, Del Pozo JL, Daly RC, Edwards BS, McGregor CGA, et al. Effect of infectious diseases on outcome after heart transplant. Mayo Clin Proc. 2008;83(3):304–8.
    Pons S, Sonneville R, Bouadma L, Styfalova L, Ruckly S, Neuville M, et al. Infectious complications following heart transplantation in the era of high ‑ priority allocation and extracorporeal membrane oxygenation. Ann Intensive Care [Internet]. 2019;9(17). Available from: https://doi.org/10.1186/s13613-019-0490-2
    Mendez-Eirin E, Paniagua-Martín MJ, Marzoa-Rivas R, Barge-Caballero E, Grille-Cancela Z, Cañizares A, et al. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: Effect of preemptive therapy. Transplant Proc [Internet]. 2012;44(9):2660–2. Available from: http://dx.doi.org/10.1016/j.transproceed.2012.09.035
    Danzinger L, Kumar D. Vaccination in Solid Organ Transplantation. Am J Transplant. 2013;13(2):311–7.
    Green M. Introduction: Infections in solid organ transplantation. Am J Transplant. 2013;13(SUPPL.4):3–8.
    Bafi AT, Tomotani DYV, De Freitas FGR. Sepsis in solid-organ transplant patients. Shock. 2017;47(12):12–6.
    Yu XY, Wang Y, Zhong H, Dou QL, Song YL, Wen H. Diagnostic value of serum procalcitonin in solid organ transplant recipients: A systematic review and meta-analysis. Transplant Proc. 2014;46(1):26–32.
    Dulek DE, Mueller NJ, Infectious AST. Pneumonia in solid organ transplantation : Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. 2019;(February):1–11.
    Ossa JE, Arango AE, Arango AM, Builes M, Arbelaez M. Prevalencia de infeccion por citomegalovirus. Acta Medica Colomb. 1987;13(3):125–8.
    Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–11.
    Husain S, Sole A, Alexander BD, Aslam S, Avery R, Benden C, et al. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary. J Hear Lung Transplant [Internet]. 2016;35(3):261–82. Available from: http://dx.doi.org/10.1016/j.healun.2016.01.007
    Colombia C de la R de. Ley 1581 de Octubre de 2012. 2012;1–15.
    REPÚBLICA DE COLOMBIA. Decreto Número 1317 De 2013 De 27 Junio 2013 [Internet]. 2013. Available from: https://www.mintic.gov.co/portal/604/articles-4274_documento.pdf
    REPÚBLICA DE COLOMBIA MINISTERIO DE SALUD. RESOLUCIÓN No 008430 DE 1993. MINISTERIO DE SALUD 1993.
    González-Vílchez F, ALmenar-Bonet L, Crespo-leiro MG, Segovia-Cubero J, González-Costello J, Arizón del Prado J, et al. Registro Español de Trasplante Cardiaco. XXX Informe Oficial de la Sección de Insuficiencia Cardiaca de la Sociedad Española de Cardiología (1984–2018). Rev Española Cardiol. 2019;72(11):954–62.
    Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: Thirty-first official adult heart transplant report-2014; Focus theme: Retransplantation. J Hear Lung Transplant. 2014;33(10):996–1008.
    Sánchez-Lázaro IJ, Almenar L, Blanes M, Martínez-Dolz L, Portoles M, Rosello E, et al. Timing, etiology, and location of first infection in first year after heart transplantation. Transplant Proc [Internet]. 2010;42(8):3017–9. Available from: http://dx.doi.org/10.1016/j.transproceed.2010.07.052
    Lin JC, Torre SR. Infectious complications in heart transplant recipients. BMC Infect Dis. 2014;14(7):53–4.
    Alba AC, Bain E, Ng N, Stein M, O’brien K, Foroutan F, et al. International Journal of Transplantation Research and Medicine Complications after Heart Transplantation: Hope for the Best, but Pre-pare for the Worst. 2016;2(2). Available from: https://www.clinmedjournals.org/articles/ijtrm/international-journal-of-transplantation-research-and-medicine-ijtrm-2-022.pdf
    Rodríguez C, Muñoz P, Rodríguez-Créixems M, Yañez JF, Palomo J, Bouza E. Bloodstream infections among heart transplant recipients. Transplantation. 2006;81(3):384–91.
    Chin-Hong P V., Schwartz BS, Bern C, Montgomery SP, Kontak S, Kubak B, et al. Screening and treatment of chagas disease in organ transplant recipients in the United States: Recommendations from the chagas in transplant working group. Am J Transplant. 2011;11(4):672–80.
    Eckardt JL, Wanek MR, Udeh CI, Neuner EA, Fraser TG, Attia T, et al. Evaluation of Prophylactic Antibiotic Use for Delayed Sternal Closure After Cardiothoracic Operation. Ann Thorac Surg [Internet]. 2020;105(5):1365–9. Available from: https://doi.org/10.1016/j.athoracsur.2017.12.012
    Pinto NC, Newman C, Gomez CA, Khush KK, Moayedi Y, Lee R, et al. Parvovirus B19-induced severe anemia in heart transplant recipients: Case report and review of the literature. Clin Transplant. 2019;33(4):1–5.
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  16. 16
  17. 17
    Academic Journal

    Alternate Title: La paloma domestica (Columba livia) y su asociación con la morbilidad respiratoria y dérmica autopercibida en un barrio de Bogotá. (Spanish)

    المصدر: Revista de Medicina Veterinaria; ene-jun2023, Issue 46, p254-289, 36p

    مصطلحات جغرافية: BOGOTA (Colombia)

  18. 18
    Academic Journal
  19. 19
  20. 20
    Academic Journal